Table 2.
Disease | n | N−/C−-CA IV positive (%) | CA IV peptide 4 positive (%) |
AIP (definite) | 15 | 4 (26.7)* | 6 (40.0)*** |
AIP (probable) | 14 | 6 (42.9)*** | 3 (21.4)** |
ACP | 15 | 2 (13.3) | 2 (13.3) |
Pancreatic cancer | 14 | 2 (14.3) | 1 (7.1) |
Sjögren’s syndrome | 20 | 9 (45.0)*** | 8 (40.0)*** |
Normal controls | 26 | 0 | 0 |
AIP, autoimmune pancreatitis; ACP, alcoholic chronic pancreatitis; N−/C−-CA IV, truncated CA IV lacking both N terminal signal and C terminal glycosyl phosphatidylinositol anchored sequences; CA IV peptide 4, NH2-LGS LTT PTC DEK VVW TVF REP I-COOH (amino acid number 221–242).
*p<0.01, **p<0.02 ***p<0.001 compared with normal controls.